Ligand Enters into OmniAb® Platform License Agreement with Pandion Therapeutics
Go back to Ligand Enters into OmniAb® Platform License Agreement with Pandion Therapeutics| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 284.47 -4.78 (1.65%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $289.25 | 52 Week High | $139.79 | |||
| Open | $291.48 | 52 Week Low | $82.07 | |||
| Day High | $294.00 | P/E | 661.56 | |||
| Day Low | $283.77 | EPS | $0.43 | |||
| Volume | 258,188 | |||||
